StockData
Avalyn Pharma Inc. logo

Avalyn Pharma Inc. (AVLN) stock

AVLNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$27.92−1.84 (-6.18%)

Close on Nov 17, 2026Market cap $1.24BP/E –Yield –

Avalyn Pharma total assets

Total assets on the balance sheet at the end of each period.

Avalyn Pharma's total assets was $425.45M at Jun 30, 2026. For fiscal 2025 it was $148.88M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$148.88M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$425.45M–
Q1 FY2026Mar 31, 2026$135.66M–
Q4 FY2025Dec 31, 2025$148.88M–

More Avalyn Pharma figures

See a number that looks wrong?